Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies

In the last decade, pieces of evidence for TDP-43-mediated mitochondrial dysfunction in neurodegenerative diseases have accumulated. In patient samples, in vitro and in vivo models have shown mitochondrial accumulation of TDP-43, concomitantly with hallmarks of mitochondrial destabilization, such as...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Chantal B. Lucini, Ralf J. Braun
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Subjects:	TDP-43 proteinopathy mitochondria mitochondrial permeabilization mtDNA apoptosis
Online Access:	https://www.mdpi.com/2227-9059/9/4/376

Similar Items

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
by: Albert Acewicz, et al.
Published: (2023-07-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 1
by: Albert Acewicz, et al.
Published: (2022-11-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
by: Juan I. López-Carbonero, et al.
Published: (2024-06-01)

Lycorine protects motor neurons against TDP-43 proteinopathy-induced degeneration in cross-species models with amyotrophic lateral sclerosis
by: Jing Wen, et al.
Published: (2024-12-01)

Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies
by: Non-Nuoc Tran, et al.
Published: (2022-09-01)

Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy
by: Besa Ziso, et al.
Published: (2015-04-01)

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
by: Juan M. Godoy-Corchuelo, et al.
Published: (2024-04-01)

TDP-43 as a potential retinal biomarker for neurodegenerative diseases
by: Margit Glashutter, et al.
Published: (2025-02-01)

Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis
by: Alessandra Pisciottani, et al.
Published: (2023-11-01)

Rapid and inducible mislocalization of endogenous TDP43 in a novel human model of amyotrophic lateral sclerosis
by: Johanna Ganssauge, et al.
Published: (2025-07-01)

TDP-43-proteinopathy at the crossroads of tauopathy: on copathology and current and prospective biomarkers
by: Abdul R. Nasir, et al.
Published: (2025-10-01)

Observation on pathological TDP ⁃ 43 in amygdala of patients with common neurodegenerative diseases
by: WANG Yuan⁃yuan, et al.
Published: (2022-09-01)

CK1δ/ε kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation
by: Vivian I. Ko, et al.
Published: (2024-06-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

Peripheral proteinopathy in neurodegenerative diseases
by: Bin Xu, et al.
Published: (2025-01-01)

Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration
by: Amit Shrestha, et al.
Published: (2015-11-01)

Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy
by: Paola Sini, et al.
Published: (2024-03-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
by: Cheng‐Chun Wu, et al.
Published: (2020-05-01)

Optogenetic induction of TDP-43 aggregation impairs neuronal integrity and behavior in Caenorhabditis elegans
by: Kyung Hwan Park, et al.
Published: (2025-04-01)

A Twist in Yeast: New Perspectives for Studying TDP-43 Proteinopathies in <i>S. cerevisiae</i>
by: Roberto Stella, et al.
Published: (2025-02-01)

Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies
by: Laetitia Miguel, et al.
Published: (2011-02-01)

TDP-43 Proteinopathies: A New Player in Neurodegenerative Diseases with Defective Protein Folding
by: Suna Lahut, et al.
Published: (2012-03-01)

Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
by: Hibiki Kawamata, et al.
Published: (2017-05-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Optineurin knock-out forms TDP-43 aggregates to regulate TDP-43 protein levels despite autophagic up-regulation and aberrant TDP-43 expression
by: Yuta Maetani, et al.
Published: (2025-07-01)

TDP-43 is a potential marker of dopaminergic neuronal damage caused by atrazine exposure
by: Guoliang Li, et al.
Published: (2023-04-01)

Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
by: R. Keating Godfrey, et al.
Published: (2023-10-01)

Oxidative stress triggers neuronal injury and mouse pain sensitization by up-regulating TDP-43 to activate mtDNA-cGAS/STING pathway
by: LI Li, et al.
Published: (2024-09-01)

Decoding TDP-43: the molecular chameleon of neurodegenerative diseases
by: Jixiang Zeng, et al.
Published: (2024-12-01)

Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo
by: Charlton G. Otte, et al.
Published: (2020-12-01)

Cryptic Splicing of GAP43 mRNA is a Novel Hallmark of TDP‐43‐Associated ALS and AD
by: Mingming Yang, et al.
Published: (2025-09-01)

Repetitive Mild but Not Single Moderate Brain Trauma Is Associated with TAR DNA-Binding Protein 43 Mislocalization and Glial Activation in the Mouse Spinal Cord
by: Tamara Janković, et al.
Published: (2025-01-01)

Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration
by: Benjamin G. Trist, et al.
Published: (2022-08-01)

Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis
by: Daniel Cacabelos, et al.
Published: (2016-04-01)

ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
by: Mai Horiuchi, et al.
Published: (2024-11-01)

TDP-43 regulates cancer-associated microRNAs
by: Xiaowei Chen, et al.
Published: (2017-09-01)